These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23013706)

  • 21. Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm.
    Pei L; Tian X; Long Y; Nan W; Jia M; Qiao R; Zhang J
    Medicine (Baltimore); 2018 Sep; 97(36):e12178. PubMed ID: 30200121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and clinical determinants influencing warfarin dosing in children with heart disease.
    Nguyen N; Anley P; Yu MY; Zhang G; Thompson AA; Jennings LJ
    Pediatr Cardiol; 2013 Apr; 34(4):984-90. PubMed ID: 23183958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients.
    Zhong SL; Yu XY; Liu Y; Xu D; Mai LP; Tan HH; Lin QX; Yang M; Lin SG
    Pharmacogenet Genomics; 2012 Mar; 22(3):176-82. PubMed ID: 22198820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.
    Sagreiya H; Berube C; Wen A; Ramakrishnan R; Mir A; Hamilton A; Altman RB
    Pharmacogenet Genomics; 2010 Jul; 20(7):407-13. PubMed ID: 20442691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose.
    Zhang X; Li L; Ding X; Kaminsky LS
    Drug Metab Dispos; 2011 Aug; 39(8):1433-9. PubMed ID: 21562147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP4F2 genetic variant alters required warfarin dose.
    Caldwell MD; Awad T; Johnson JA; Gage BF; Falkowski M; Gardina P; Hubbard J; Turpaz Y; Langaee TY; Eby C; King CR; Brower A; Schmelzer JR; Glurich I; Vidaillet HJ; Yale SH; Qi Zhang K; Berg RL; Burmester JK
    Blood; 2008 Apr; 111(8):4106-12. PubMed ID: 18250228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
    Shaw K; Amstutz U; Hildebrand C; Rassekh SR; Hosking M; Neville K; Leeder JS; Hayden MR; Ross CJ; Carleton BC
    Pediatr Blood Cancer; 2014 Jun; 61(6):1055-62. PubMed ID: 24474498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial.
    Zhang L; Zheng X; Long Y; Wu M; Chen Y; Yang J; Liu Z; Zhang Z
    J Thromb Haemost; 2017 Oct; 15(10):1934-1941. PubMed ID: 28762606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.
    Shahin MH; Khalifa SI; Gong Y; Hammad LN; Sallam MT; El Shafey M; Ali SS; Mohamed ME; Langaee T; Johnson JA
    Pharmacogenet Genomics; 2011 Mar; 21(3):130-5. PubMed ID: 21228733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study.
    Lee KE; Yee J; Lee GY; Chung JE; Seong JM; Chang BC; Gwak HS
    Sci Rep; 2020 Apr; 10(1):6988. PubMed ID: 32332930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis.
    Zhang J; Chen Z; Chen C
    Meta Gene; 2016 Sep; 9():197-209. PubMed ID: 27617219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of single nucleotide polymorphisms in c-Myc on stable warfarin doses in patients with cardiac valve replacements.
    Lee KE; Chang BC; Park S; Gwak HS
    Pharmacogenomics; 2015; 16(10):1101-8. PubMed ID: 26249541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement.
    Cao H; Wu T; Chen W; Fu J; Xia X; Zhang J
    Int J Clin Pharm; 2020 Jun; 42(3):861-870. PubMed ID: 32410208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Warfarin pharmacogenetics: a controlled dose-response study in healthy subjects.
    Kadian-Dodov DL; van der Zee SA; Scott SA; Peter I; Martis S; Doheny DO; Rothlauf EB; Lubitz SA; Desnick RJ; Halperin JL
    Vasc Med; 2013 Oct; 18(5):290-7. PubMed ID: 24029542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
    Takeuchi F; McGinnis R; Bourgeois S; Barnes C; Eriksson N; Soranzo N; Whittaker P; Ranganath V; Kumanduri V; McLaren W; Holm L; Lindh J; Rane A; Wadelius M; Deloukas P
    PLoS Genet; 2009 Mar; 5(3):e1000433. PubMed ID: 19300499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves.
    Chung JE; Chang BC; Lee KE; Kim JH; Gwak HS
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1229-36. PubMed ID: 26257249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese.
    Zeng WT; Xu Q; Li CH; Chen WY; Sun XT; Wang X; Yang YY; Shi H; Yang ZS
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1327-1334. PubMed ID: 27488389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction.
    Kringen MK; Haug KB; Grimholt RM; Stormo C; Narum S; Opdal MS; Fosen JT; Piehler AP; Johansen PW; Seljeflot I; Berg JP; Brørs O
    J Biomed Biotechnol; 2011; 2011():739751. PubMed ID: 21127708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of apolipoprotein E (APOE) polymorphisms with warfarin maintenance dose in a northern Han Chinese population.
    Liu R; Zhang K; Gong ZZ; Shi XM; Zhang Q; Pan XD; Dong R
    Lipids Health Dis; 2016 Feb; 15():34. PubMed ID: 26912074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of
    Al-Eitan LN; Almasri AY; Alnaamneh AH; Aman HA; Alrabadi NN; Khasawneh RH; Alghamdi MA
    Int J Med Sci; 2021; 18(3):826-834. PubMed ID: 33437219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.